PharmaTell seminar: Biomedical polymers for ophthalmic applications – from topical eye drops to scleral implants Event as iCalendar

(Seminars)

27 August 2014

12 - 1pm

Venue: Seminar Room 505-364, Grafton Campus

Host: School of Pharmacy

Contact info: Phone: +64 9 373 7599 ext 82851

Contact email: enquiries@auckland.ac.nz

Ilva Rupenthal
Dr Ilva Rupenthal

Polymeric systems have overcome some of the issues associated with conventional eye drops by prolonging corneal residence time, increasing tissue permeation and sustaining drug release. This presentation will give an overview of the research performed at the Buchanan Ocular Therapeutics Unit with regards to biomedical polymers. This includes the evaluation of in situ gelling eye drops for topical delivery, the assessment of PLGA nano- and microparticles for controlled peptide release after intravitreal injection and the development of novel stimuli-responsive implants for ondemand retinal drug delivery.


Presented by: Dr Ilva Rupenthal
Director of the Buchanan Ocular Therapeutics Unit

Dr Rupenthal is a Senior Lecturer in the Department of Ophthalmology and the inaugural Director of the Buchanan Ocular Therapeutics Unit, which aims to translate ocular therapeutic related scientific research into the clinical setting. Ilva received a BPharm from Philipps-University of Marburg, Germany, in 2003 and completed a PhD on ‘Ocular delivery of antisense oligonucleotides’ with the School of Pharmacy and the Department of Ophthalmology in 2008. In 2010, Ilva was awarded a three-year New Zealand Science and Technology Postdoctoral Fellowship to establish an ophthalmic pharmaceutics group within the New Zealand National Eye Centre. Dr Rupenthal has received several awards including the 2014 University of Auckland Early Career Research Excellence Award and the 2013 HRC Sir Charles Hercus Research Fellowship.